Notification of Major Interes

RNS Number : 4843H

Alliance Pharma PLC

22 February 2010

 



For Immediate Release

22 February 2010

ALLIANCE PHARMA PLC

TR - 1:

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			ALLIANCE PHARMA PLC (ISIN: GB0031030819)
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	Changes to disclosure requirements			X
3. Full name of person(s) subject to the notification obligation: iii		NIGEL WILLIAM WRAY
4. Full name of shareholder(s)  (if different from 3.):iv		PERSHING NOMINEES LIMITED      SMITH & WILLIAMSON NOMINEES LIMITED ROY NOMINEES LIMITED
5. Date of the transaction and date on which the threshold is crossed or reached: v		22 FEBRUARY 2010
6. Date on which issuer notified:		22 FEBRUARY 2010
7. Threshold(s) that is/are crossed or reached: vi, vii		10%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY SHARES GB0031030819

21,469,995

21,469,995

24,319,995

10.95%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

24,319,995

10.95%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Nigel William Wray has a beneficial interest in shares in Alliance Pharma Plc held by the following nominees Pershing Nominees Limited 8,705,407 Smith & Williamson Nominees Limited 50,000  ROY NOMINEES LIMITED   - 15,564,588
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	N/A
14. Contact name:	Nigel Wray
15. Contact telephone number:	020 7647 7647

 

END

 

 

HOLEAAAAADNEEFF